Advertisement

Topics

Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes

11:29 EDT 14 Mar 2018 | Drug Discovery Development

The anti-inflammatory drug canakinumab had no effect on rates of newly diagnosed diabetes in people who had prediabetes (elevated blood sugar levels at risk of developing into diabetes).
Contributed Author: 
American College of Cardiology
Topics: 

Original Article: Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes

NEXT ARTICLE

More From BioPortfolio on "Canakinumab Doesn’t Prevent Prediabetes from Progressing to Diabetes"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...